Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th

Date : 02/05/2008 @ 5:00PM
Source : PR Newswire
Stock : Palatin Technologies (PTN)
Quote : 0.13  0.0 (0.00%) @ 4:00PM
<< BackQuote Chart Financials

 



Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th

CRANBURY, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (AMEX:PTN) will announce its second quarter, fiscal year 2008 financial results for the period ended December 31, 2007 on February 11, 2008 before the open of the U.S. financial markets.

The Company will also conduct a teleconference and live audio webcast hosted by Palatin's executive management team on February 11, 2008 at which they will discuss the results of operations in greater detail and provide an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call and Webcast

-- Q2-Fiscal Year 2008 Financial Results 2/11/2008 at 7:30 a.m. ET Press Release

-- Q2-Fiscal Year 2008 Conference 2/11/2008 at 11:00 a.m. ET Call - Live Domestic Dial-In Number 1-888-686-9699 International Dial-In Number 1-913-312-6699

-- Q2-Fiscal Year 2008 Conference 2/11-2/18/2008 Call - Replay Domestic Dial-In Number 1-888-203-1112 International Dial-In Number 1-719-457-0820 Replay Passcode: 6144795

-- Webcast Live and Replay Access http://www.palatin.com/ The webcast and replay can be accessed by logging on to the "Investor Center-Webcasts" section of Palatin's website at http://www.palatin.com/.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com/.

DATASOURCE: Palatin Technologies, Inc.

CONTACT: Stephen T. Wills, CPA, MST, EVP-Operations / Chief Financial

Officer of Palatin Technologies, +1-609-495-2200, ; or

Institutional Investors and Media, Carney Noensie of Burns McClellan,

+1-212-213-0006,

Web site: http://www.palatin.com/

<< Back


Palatin Technologies Historical Chart Palatin Technologies Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us 081007 20:30 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )